NCT06376227Completed
Robotic-Assisted or Laparoscopic Radical Resection for Rectal Cancer With or Without Left Colic Artery Preservation
With or Without Left Colic Artery Preservation
Source: ClinicalTrials.gov · Last updated 22 Apr 2024
Brief summary (registry, in English)
Brief Summary Background The preservation of the left colic artery (LCA) during rectal cancer resection remains a topic of controversy, and there is a notable absence of robust evidence regarding the outcomes associated with LCA preservation. And the advantages of robotic-assisted laparoscopy (RAL) surgery in rectal resection remain uncertain. The objective of this study was to assess the influence of LCA preservation surgery and RAL surgery on intraoperative and postoperative complications of rectal cancer resection. Methods Participants who underwent laparoscopic (LSC) or RAL with or without LCA preservation resection for rectal cancer between April 2020 and May 2023 were retrospectively assessed. The patients were categorized into two groups: low ligation (LL) which with preservation of LCA and high ligation (HL) which without preservation of LCA. A one-to-one propensity score-matched analysis was performed to decrease confounding. The primary outcome was operative findings, operative morbidity, and postoperative genitourinary function.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1164 (actual)
- First submitted
- 10 Apr 2024
- Start date
- 1 Apr 2020
- Primary completion date
- 31 May 2023
- Lead sponsor
- Northern Jiangsu People's Hospital
- Diseases
- Colorectal cancer
- NCT number
- NCT06376227
What you commit to
- Study type: Observational
- Participants enrolled: 1164
- From 1 Apr 2020 to the primary completion date, 31 May 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Emergency surgery
- Palliative surgery
- No standard chemotherapy for tumor-node-metastasis (TNM) staging II or III after surgery
Other illness
- Recurrent rectal cancer
- A postoperative pathology report that showed residual cancer cells at the proximal or distal resection margin
Other
- Preoperative and intraoperative detection of distant organ metastases or extensive
- Implantation metastases in the abdominal cavity
- Synchronous colorectal carcinoma and other organ tumors
- Incomplete case data.
Who the study is looking for
- Low anterior resection for rectal cancer
- Postoperative pathological diagnosis of rectal adenocarcinoma
- Informed consent signed prior to surgery.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Northern Jiangsu People's Hospital Affiliated to Yangzhou University, General Surgery Institute of Yangzhou, Yangzhou University , Yangzhou Coordinator of this site? Confirm its status | Yangzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.